Comparison of Adverse Events between Ramipril and Perindopril in Contemporary Cardiac Practice
Annals of Clinical Cardiology · 2021
DOI: 10.4103/accj.accj_12_21 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical Cardiology, 2021. Verfasst von Ramesh Sankaran und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
Angiotensin-converting enzyme inhibitors (ACEIs) are extensively used for the treatment and management of cardiovascular diseases. Although ACEIs are a well-tolerated medication in high percentage of patients, around 30% can develop adverse reactions like dry cough.
Objective
The objective of the study was to capture the incidence of cough in patients with cardiovascular diseases that were prescribed with perindopril and ramipril in an Indian tertiary care hospital.
Methods
In this observational study, the incidence of cough in patients with cardiovascular diseases that were prescribed with perindopril and ramipril was estimated.
Results
A total of 223 patients were enrolled in this study. Around 50.67% patients received ramipril; among them, 6.02% received 1.25 mg, 78.95% received 2.5 mg, and 13.53% received 5 mg of ramipril. Around 35.9% ( n = 80) patients received perindopril. In perindopril group, 31.3% of the patients received 2 mg dose and 68.8% of patients received 4 mg dose. Among perindopril group, the incidence of cough was observed in 10% ( n = 8) of the patients, whereas in ramipril group, it was 19.55% ( P = 0.00136). Due to cough, in perindopril group, 6.3% (5/80) of the patients discontinued treatment whereas in ramipril group, 9% (12/133) of the patients discontinued treatment medication.
Conclusions
Our study has demonstrated that perindopril has been associated with a relatively low incidence of cough compared to ramipril.
Zitieren
APA
Sankaran, R., Senguttuvan, N., Muralidharan, T. R., Balakrishnan, V., Sadhanandham, S., Panchanatham, M., Balasubramaniyan, J. V., Krishnamurthy, P., & Badimela, P. (2021). Comparison of Adverse Events between Ramipril and Perindopril in Contemporary Cardiac Practice. Annals of Clinical Cardiology. https://doi.org/10.4103/accj.accj_12_21
Vancouver
Sankaran R, Senguttuvan N, Muralidharan TR, Balakrishnan V, Sadhanandham S, Panchanatham M, et al. Comparison of Adverse Events between Ramipril and Perindopril in Contemporary Cardiac Practice. Annals of Clinical Cardiology. 2021. doi:10.4103/accj.accj_12_21
BibTeX
@article{Sankaran2021,
author = {Sankaran, Ramesh and Senguttuvan, Nagendraboopathy and Muralidharan, Thoddi Ramamurthy and Balakrishnan, Vinodkumar and Sadhanandham, Shanmugasundaram and Panchanatham, Manokar and Balasubramaniyan, Jayanthy Venkata and Krishnamurthy, Preetham and Badimela, Phulgun},
title = {Comparison of Adverse Events between Ramipril and Perindopril in Contemporary Cardiac Practice},
journal = {Annals of Clinical Cardiology},
year = {2021},
doi = {10.4103/accj.accj_12_21}
}
EUVIMED